Correction regarding the Stock exchange release: Biohit Oyj's 2020 Annual general meeting
Biohit Oyj Correction
Biohit takes the threat of the Corona virus extremely seriously. Based on the development of the Corona virus situation and the policy of the Finnish Government Biohit has decided to convene the Annual General Meeting at a later stage, when the Corona virus does not cause any risks for the health of the participants.
Helsinki, 27 March 2020
Board of Directors
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com